Publication: Oral targeted therapy and chronic lymphocytic leukemia in Canada
-
Learn morePublication: Fixed-duration oral targeted therapies and chronic lymphocytic leukemia in Canada
A study evaluating, from a Canadian perspective, the impact of fixed-duration targeted therapies on the economic burden of chronic lymphocytic leukemia. Impact of Fixed-Duration Oral…
-
Learn morePublication: Venetoclax and azacitidine for acute myeloid leukemia in Canada
A study evaluating, from a Canadian perspective, the economic impact of venetoclax in combination with azacitidine for the treatment of patients with acute myeloid leukemia.…
-
Learn morePublication: Network meta-analysis on latanoprostene bunod and glaucoma
A network meta-analysis by our team focusing on the treatment of glaucoma: Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular…